SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-091969
Filing Date
2024-08-06
Accepted
2024-08-06 17:01:38
Documents
16
Effectiveness Date
2024-08-06

Document Format Files

Seq Description Document Type Size
1 S-8 dvax-20240806.htm S-8 181408
2 EX-5.1 dvax-ex5_1.htm EX-5.1 14554
3 EX-23.1 dvax-ex23_1.htm EX-23.1 3473
4 EX-FILING FEES dvax_exfilingfees.htm   iXBRL EX-FILING FEES 40158
5 GRAPHIC img177246339_0.jpg GRAPHIC 53909
  Complete submission text file 0000950170-24-091969.txt   447260

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT dvax_exfilingfees_htm.xml XML 5887
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281307 | Film No.: 241180295
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)